DJIA 16,979.13 59.54 0.35%
NASDAQ 4,526.48 -1.03 -0.02%
S&P 500 1,986.51 4.91 0.25%
market minute promo

Geron Corp (NASDAQ: GERN)



company name or ticker

Geron's (GERN) CEO John Scarlett on Q2 2014 Results - Earnings Call Transcript

Geron's (GERN) CEO John Scarlet on Q2 2014 Results - Earnings Call Transcript

3 Longtime Losers About to See Green?

These 3 biotechs have lost tons of money every year so far in the 21st century. But could profits be on the horizon?

Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market

Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation

Better Buy: Dynavax Technologies Corp. vs. Geron Corp.

Dynavax Technologies Corp. and Geron Corp. have pending catalysts that could cause their shares to double from current levels. Here's a Foolish look at which company offers the better risk-to-reward profile.

Geron Corp. (GERN) Jumps: Stock Moves 8.1% Higher - Tale of the Tape

Geron (GERN) Enters Overbought Territory - Tale of the Tape

Will Investors Profit from Geron's Road to Recovery?

Geron gets a clinical hold released, but is still a ways away from competing with Incyte's Jakafi.

A Beaten-Down Biotech Stock Poised for an Epic Short Squeeze

See More Articles...